A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022.

Swiss generic drug manufacturer Sandoz has agreed to pay $275 million to resolve claims by U.S. consumers and others who ...

MSK plans to speed up early-stage drug development by using AWS Drug Discovery Workbench to screen potential candidates.

To control cholesterol levels, people are encouraged to follow a healthy diet, observe weight management, and get regular exercise ...

The Hunter Medical Research Institute (HMRI) has signed a memorandum of understanding (MoU) with Novartis Australia for ...

E. Merck KG board of partners has announced the appointment of new CEOs to Merck KGaA’s executive board, aiding its ongoing growth strategy.

On February 13, 2025, the FDA approved Samsung Bioepis Co., Ltd.’s denosumab biosimilars, OSPOMYV™ (denosumab-dssb; 60 mg pre-filled syringe) ...

"They don't bring forward proposals, but act as judges, prosecutors, experts, they pander to the public, they spew filth, and ...

Hello there. I don’t know if Mitsotakis got off easy back in 2018 with the rolling suitcases of the Novartis scandal—"the scandal of the century," as Mimi ...